Christophe Sajous

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Metastatic Colorectal Cancer

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JNCI cancer spectrum

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Pauline Corbaux, Gilles Freyer, Olivier Glehen, Benoit You, Naoual Bakrin, Audrey Gelot, David Dayde, Christophe Sajous, Max Piffoux, Julien Péron, Gaelle Lescuyer, Léa Payen, Vahan Kepenekian
Intraperitoneal Nivolumab After Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Pauline Corbaux, Gilles Freyer, Olivier Glehen, Benoit You, Naoual Bakrin, Audrey Gelot, David Dayde, Christophe Sajous, Max Piffoux, Julien Péron, Gaelle Lescuyer, Léa Payen, Vahan Kepenekian
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, Marie Attard, Claire Bournaud, Ludovic Lacroix, Danielle Benisvy, David Taïeb, Stephane Bardet, Marie Terroir, Nadege Anizan, Emilie Bouvier-Morel, Livia Lamartina, Georges Lion, Sarah Bétrian, Christophe Sajous, Aurelie Schiazza, Marie-Eve Garcia, Renaud Ciappuccini, Martin Schlumberger, Abir Al Ghuzlan, Yann Godbert, Isabelle Borget
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E Mutated Differentiated thyroid Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Denis Maillet, Nathalie Allioli, Julien Péron, Adriana Plesa, Myriam Decaussin-Petrucci, Sophie Tartas, Christophe Sajous, Alain Ruffion, Sébastien Crouzet, Gilles Freyer, Virginie Vlaeminck-Guillem
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers 13 (23) (2021)
Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, Sara Calattini, Stéphanie Cartalat, Marion Chauvenet, Marc Colombel, Stéphane Dalle, Tristan Dagonneau, Marie Darrason, Gilles Devouassoux, Michaël Duruisseaux, Marielle Guillet, Olivier Glehen, Pierre Philouze, François Tronc, Thomas Walter, Benoît You, Gilles Freyer
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL). Cancers 14 (1) (2021)
Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, Slimane Dermeche, Jean-Christophe Eymard, Sabrina Falkowski, Marine Gross-Goupil, Gabriel Malouf, Bérangère Narciso, Christophe Sajous, Sophie Tartas, Eric Voog, Alain Ravaud
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies? Cancers 13 (21) (2021)
Olivier Colomban, Michel Tod, Julien Peron, Timothy J Perren, Alexandra Leary, Adrian D Cook, Christophe Sajous, Gilles Freyer, Benoit You
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7). JNCI cancer spectrum 4 (3) (2020)
Margaux Hubert, Elisa Gobbini, Coline Agnes Couillault, Thien-Phong Vu Manh, Anne-Claire Doffin, Justine Berthet, Céline Rodriguez, Vincent Ollion, Janice Kielbassa, Christophe Sajous, Isabelle Treilleux, Olivier Trédan, Bertrand Dubois, Marc Dalod, Nathalie Bendriss-Vermare, Christophe Caux, Jenny Valladeau-Guilemond
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. Science immunology 5 (46) (2020)